Document is current
Any future updates will be listed below
-
Authors
Gottlieb, Assaf https://orcid.org/0000-0003-4904-631X
Daneshjou, Roxana
DeGorter, Marianne
Bourgeois, Stephane
Svensson, Peter J.
Wadelius, Mia
Deloukas, Panos
Montgomery, Stephen B.
Altman, Russ B.
-
Funding
Funding for this research was provided by:
U.S. National Library of Medicine (LM05652, LM05652)
National Institute of General Medical Sciences (GM061374, GM061374)
Paul and Daisy Soros Fellowships for New Americans
Banting Research Foundation
Edward Mallinckrodt Jr. Foundation
National Institute of Mental Health (R01MH101814)
National Human Genome Research Institute (U01HG007436, U01HG00908001)
British Heart Foundation (RG/14/5/30893)
Hjärt-Lungfonden (20120557, 20140291)
Vetenskapsrådet (521-2011-2440, 521-2014-3370)
- License Information
-
More Information
Article History
Received: 16 August 2017
Accepted: 14 November 2017
First Online: 24 November 2017
Ethics approval and consent to participate
: The EUR training warfarin study was approved by the Human Subjects Review Committee at the University of Washington and informed consent was obtained in accordance with the Declaration of Helsinki, as described in Cooper et al. [].
: The EUR validation cohort study was approved by the Regional Ethics Committee in Lund, Sweden, and informed consent was obtained in accordance with the Declaration of Helsinki [].
: For the AA training cohort, all patients consented using an Institutional Review Board–approved process at each respective collection site in accordance with the Declaration of Helsinki, as described in Daneshjou et al. [].
: For the AA validation cohort, all participants gave written informed consent to participate and all protocols were approved by local institutional review boards, as described in Isma et al. [].
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
